HomeESLA • NASDAQ
add
Estrella Immunopharma Inc
Previous close
$2.12
Day range
$2.00 - $2.13
Year range
$0.73 - $3.15
Market cap
75.53M USD
Avg Volume
322.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
CityNews Halifax
22 hours ago
S&P/TSX composite index rises 200 points, U.S. stock markets also higher
0.082%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.80M | 42.18% |
Net income | -4.80M | -922.54% |
Net profit margin | — | — |
Earnings per share | -0.13 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.63M | -65.59% |
Total assets | 3.52M | -59.19% |
Total liabilities | 13.36M | 9,546.79% |
Total equity | -9.84M | — |
Shares outstanding | 37.77M | — |
Price to book | -8.15 | — |
Return on assets | -369.09% | — |
Return on capital | 150.76% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -4.80M | -922.54% |
Cash from operations | -727.33K | 67.20% |
Cash from investing | — | — |
Cash from financing | 1.04M | 789.43% |
Net change in cash | 310.02K | 113.09% |
Free cash flow | 1.20M | 129.67% |
About
Founded
2006
Headquarters
Website
